FundraisingTelecoms
Inside Information / Other news releases
05/11/2026 08:00
AMFImmediate publication
Rome (Italy), 5 November 2026 – Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN: IT0005450819, the “Company”), further to its press releases of 28 and 29 October 2026, announces the admission to trading on Euronext Growth Paris of 1,000,000 new ordinary shares (the “New Shares”)…
Mexedia S.p.A. S.B.
Via di Affogalasino, 105 - 00148
Rome RM, Italy
T: +39 (06) 94502581 mexedia.com
PEC: mexediaspa@legalmail.it
Cap. Soc.: € 57.320.000,00 i.v.
P.IVA e C.F: 15997541006
REA: 1627922
PRICE SENSITIVE
PRESS RELEASE
ADMISSION TO TRADING OF THE NEW SHARES ISSUED UNDER THE FIRST TRANCHE OF THE
CAPITAL INCREASE RESERVED TO LIKAN AG
Admission of 1,000,000 new ordinary shares to trading on Euronext Growth Paris
Rome (Italy), 5 November 2026 – Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN: IT0005450819, the “Company”), further to its press releases of 28 and 29 October 2026, announces the admission to trading on Euronext Growth Paris of 1,000,000 new ordinary shares (the “New Shares”) issued under the first tranche of the capital increase reserved to Likan AG (the “Investor”).
The Transaction
As announced to the market on 29 October 2026, the Company signed with the Investor, a company incorporated under Swiss law with registered office in Zug, a fixed-price equity investment agreement for an amount of up to EUR 20,000,000 (the “Agreement”), in implementation of the resolution adopted by the Extraordinary Shareholders’ Meeting of 28 October 2026. The capital increase is reserved to the Investor, with exclusion of the pre-emption right pursuant to Article 2441(5) of the Italian Civil Code, and is executed on a divisible basis and in tranches (the “Transaction”).
Upon signing of the Agreement, the Investor subscribed for and fully paid the first tranche, amounting to EUR 1,000,000, at the fixed price of EUR 1.00 per share, of which EUR 0.02 allocated to share capital and EUR 0.98 to share premium. The terms of the Transaction are described in the Company’s press releases of 28 and 29 October 2026, to which reference is made.
Admission to trading
The New Shares, which have the same characteristics as the outstanding ordinary shares, are admitted to trading on Euronext Growth Paris as from 5 November 2026.
The shares issued under subsequent tranches will be the subject of an application for admission to trading following their issuance. The Company will inform the market accordingly, in compliance with applicable regulations.
Share capital
Following the issuance of the New Shares, the Company’s subscribed and paid-up share capital amounts to EUR 57,340,000, represented by 9,353,129 ordinary shares with no nominal value.